Last updated: 04/21/2020 16:00:06

Benefit of patient referral to epilepsy centers in Japan

GSK study ID
200374
See study documents
Clinicaltrials.gov ID
Not applicable
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Overview
Eligibility
Locations
Study documents
Results summary
Plain language summaries
Additional information

Trial overview

Official title: Benefit of patient referral to epilepsy centers in Japan
Trial description: The purpose of this investigation is to evaluate benefit of patinet referral to epilepsy centers by using questionnaires related to quality of life QOLIE-31p.
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:

QOLIE- 31p score

Timeframe: 0,3,6 month

seizure frequency

Timeframe: 0, 3, 6 month

Secondary outcomes:

QOLIE-31p sub scale score

Timeframe: 0,3,6 month

Interventions:
Not applicable
Enrollment:
51
Primary completion date:
2015-10-08
Observational study model:
Cohort
Time perspective:
Prospective
Clinical publications:
Not applicable
Medical condition
Epilepsy
Product
lamotrigine
Collaborators
Not applicable
Study date(s)
February 2014 to August 2015
Type
Observational
Phase
Not applicable

Participation criteria

Sex
Female & Male
Age
18 - 70 Years
Accepts healthy volunteers
Not applicable
  • Inclusion Criteria:
  • 1. Patients with epilepsy (including a suspected case)
Inclusion and exclusion criteria
Inclusion criteria:
  • Inclusion Criteria: 1. Patients with epilepsy (including a suspected case) 2. Patients with a history of epilepsy treatment (including a suspected case) 3. Patients referred from other medical institution due to epilepsy (including a suspected case) 4. Patients aged 18 years or older (at the time point of obtaining consent) 5. Patients who are capable of answering the Investigation Form without another person’s aid 6. Patients who are capable of submitting the written consent by themselves and/or proxy consent giver 7. Referred patients whose treatment requires interventionPatients whom intervention is (or being) decided for . 8. Gender: eitherno object 9. Patients who are capable of complying with the investigation procedures Exclusion Criteria 1. Patients who are judged inappropriate to participate in this investigation by the investigator or subinvestigator

Trial location(s)

This study does not involve prospective enrollment of participants.

Study documents

Scientific result summary
Available language(s): English
Download document(s)

If you wish to request for full study report, please contact - [email protected]

Results overview

Refer to study documents

Recruitment status
Study complete
Actual primary completion date
2015-10-08
Actual study completion date
2015-10-08

Plain language summaries

Not applicable. GSK’s transparency policy provides for Plain Language Summaries for Interventional studies.

Additional information about the trial

Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website